Abstract
The diversity of plant natural products presents a rich resource for accelerating drug discovery and addressing pressing human health issues. However, the challenges in accessing and cultivating source species, as well as metabolite structural complexity, and general low abundance present considerable hurdles in developing plant-derived therapeutics. Advances in high-throughput sequencing, genome assembly, gene synthesis, analytical technologies, and synthetic biology approaches, now enable us to efficiently identify and engineer enzymes and metabolic pathways for producing natural and new-to-nature therapeutics and drug candidates. This review highlights challenges and progress in plant natural product discovery and engineering by example of recent breakthroughs in identifying the missing enzymes involved in the biosynthesis of the anti-cancer agent Taxol®. These enzyme resources offer new avenues for the bio-manufacture and semi-synthesis of an old blockbuster drug.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Plants are remarkable biochemists; they produce a wealth of bioactive small-molecule chemicals to mediate developmental processes, communicate with other organisms, and adapt to dynamic ecological environments. From the use of yarrow and chamomile by Neanderthalian cultures, nearly 50,000 years ago (Hardy et al. 2012), to traditional medicines developed by ancient civilizations, across the globe, humans have benefitted from the diversity of herbal remedies to treat ailments and diseases. Today, almost a third of World Health Organization essential medicines find their origin in plant natural products (De Luca et al. 2012; Raskin et al. 2002). Faced with increasing health challenges of a burgeoning world population, the large-scale production of clinically used therapeutics and the discovery of new drug leads are a matter of utmost urgency.
Traditional production approaches
The diversity of plant natural products can provide a critical resource in this endeavor if challenges toward their production can be overcome. Traditional methods of isolating bioactive products from the source species have laid the foundation for many modern pharmaceuticals (Hartmann 2007). However, this strategy is often impractical, due to the lack of scalable cultivation, low product accumulation often in only specific tissues and in response to environmental stimuli, and the need to protect rare and endangered species. Over the past century, chemical synthesis has successfully provided high-purity therapeutics and other bioproducts (Guerra-Bubb et al. 2012; Hetzler et al. 2022), but is often constrained by high costs, the toxicity of waste products, and the structural complexity of plant natural products.
The transition to modern omics approaches: Taxol as a case study
The availability of large omics data, paired with inexpensive DNA synthesis, has revolutionized the discovery of enzymes and pathways underlying the biosynthesis of desired products (Li et al. 2023; Owen et al. 2017; Tiedge et al. 2020). Applying this resource to metabolic engineering, in heterologous microbial or plant platforms, now offers unprecedented possibilities for manufacturing natural and new-to-nature bioproducts with superior stereo-control and at an industrial scale using enzymatic and semi-synthetic approaches (Chen et al. 2024; Owen et al. 2017; Wurtzel and Kutchan 2016).
The diterpenoid anti-cancer drug Paclitaxel (Taxol®) exemplifies the various bottlenecks one can encounter in producing plant-derived therapeutics. Following its discovery in a drug screen of more than 100,000 plant natural products in the late 1960s, Taxol quickly became a leading chemotherapeutic, due to its unique mode of action in arresting mitosis and ultimately cell division by preventing microtubule disassembly and its broad-spectrum activity against several cancer types (Arnst 2020).
Taxol was first isolated from its natural source, Pacific yew (Taxus brevifolia) (Wani et al. 1971). However, coniferous yew trees do not present a sustainable resource, as they grow slowly and in only narrow climatic niches and produce only low amounts of Taxol. Moreover, the isolation of Taxol from bark tissue is destructive, which resulted in overharvesting to the extent that some yew species, historically used for commercial extraction, have been placed on the endangered species list by the International Union for Conservation of Nature (Mayor 2011). This limited natural supply chain has inspired many efforts, over the past six decades, to devise Taxol production strategies that can meet ever-increasing clinical demand (Fig. 1).
Numerous total synthesis routes for Taxol and key precursors have been established, but often require long and expensive routes due to the structural complexity of Taxol (Guerra-Bubb et al. 2012; Watanabe et al. 2023; Zhang et al. 2023a). Early work on the Taxol biosynthetic pathway facilitated the development of cell suspension cultures of Taxus needles to produce key precursors, such as 10-deacetyl-baccatin III with high stereochemical precision (Hezari et al. 1997; Ketchum et al. 2007, 2003). Semi-synthetic approaches, utilizing these precursors as starting material, have proven a more renewable and scalable strategy and are currently the major platform for commercial Taxol production (Arya et al. 2020; Roberts 2007).
Rapid advances in synthetic biology have the potential to offer less costly and more sustainable avenues for Taxol manufacture but necessitate knowledge of the underlying enzymes and pathways. Such resources would not only enable improved Taxol production in existing and new metabolic engineering and semi-synthetic platforms but also facilitate combinatorial metabolic engineering of Taxol-biosynthetic enzymes, to thereby gain access to a broader range of the more than 600 known taxane and taxoid structures with potentially desirable therapeutic efficacies (Lange and Conner 2021).
These applications have steered long-standing research efforts in elucidating the multi-enzyme Taxol-biosynthetic pathway. In particular, the pioneering work by Croteau and colleagues resulted in the discovery of many of the core reactions and associated enzymes of Taxol formation (Guerra-Bubb et al. 2012; Jennewein and Croteau 2001; Walker and Croteau 2001) (Fig. 2). This includes the diterpene synthase, taxadiene synthase (TXS), catalyzing the conversion of the universal diterpenoid precursor, geranylgeranyl diphosphate (GGPP), into taxadiene as the committed reaction in building the core taxane scaffold (Hezari et al. 1995; Lin et al. 1996; Wildung and Croteau 1996). In later years, several cytochrome P450 monooxygenases (P450) and acyl- and benzoyl-transferases, which functionally decorate taxadiene, were characterized (Guerra-Bubb et al. 2012; Srividya et al. 2020).
Equipped with this pathway knowledge, the metabolic engineering of taxol precursors, especially taxadiene and taxadiene-5ɑ-ol, using microbial and plant platforms could be established, including yeast (Saccharomyces cerevisiae) (Nowrouzi et al. 2024, 2020; Walls et al. 2021), Escherichia coli (Ajikumar et al. 2010; Biggs et al. 2016; Chang et al. 2007) and Nicotiana benthamiana (De La Peña and Sattely 2021; Hasan et al. 2014; Li et al. 2019). Notably, product yields varied across studies and host systems, as exemplified by taxadiene titers reaching 103 mg L−1 in yeast, 1 g L−1 in E. coli, and 100 µg g−1 fresh weight in N. benthamiana. Despite these many advances, several enzymes essential for forming the core baccatin III intermediate, alongside additional modifications and formation of the complete aromatic side chain have remained elusive until recently.
What has been the challenge? Low abundance, diversity, and structural complexity of naturally occurring taxanes and related structures in species of Taxus have hindered access to pathway intermediates required for the biochemical testing of enzyme functions. Even if substrates are available, the functional diversity and catalytic promiscuity of the large P450 and transferase enzyme families predicted to be involved in Taxol formation, along with often low protein expression and activity in heterologous systems, has slowed progress in identifying pathway enzymes and understanding the pathway organization of Taxol biosynthesis.
Taxus genomes: platform for missing enzyme discovery
Sequencing and assembly of the > 10 Gb genomes of two Taxus species provided a critical milestone in the quest for Taxol biosynthesis (Cheng et al. 2021; Xiong et al. 2021). Recent efforts have leveraged this resource to identify the missing enzymes and reactions to complete the Taxol pathway, marking a significant breakthrough in our understanding and metabolic engineering of Taxol biosynthesis. Integrating genomics, synthetic biology, and enzyme biochemical approaches, Jiang and coworkers elegantly elucidated two P450 enzymes that catalyze two previously unresolved functional modifications essential for Taxol bioactivity (Jiang et al. 2024) (Fig. 2).
Mining of the Taxus genomes revealed new members of the Taxus-specific CYP725 P450 family with known functions in Taxol formation (Kaspera and Croteau 2006). To enable P450 functional testing, these authors combined co-infiltration of substrate isolated from plant tissue with co-expression of P450 candidates and known pathway enzymes in N. benthamiana and insect cell cultures. This strategy resulted in the identification of Taxane Oxetanase 1 (TOT), a bifunctional CYP725 P450 that facilitates the addition of the characteristic oxetane ring to the taxane scaffold (Jiang et al. 2024) (Fig. 2). Functional analysis of insect microsomal fractions containing TOT and knock-down of TOT in Taxus cell cultures verified TOT functionality.
Next, Jiang et al. (2024) employed pathway engineering to generate the alternate intermediate, taxusin, and used this platform to functionally screen the remaining CYP725 candidates, leading to the discovery of taxane-9ɑ-hydroxylase (T9ɑH) that catalyzes the missing oxygenation at the C-9 position. With these enzymes in hand, the authors reconstituted the conversion of the universal diterpenoid precursor, geranylgeranyl diphosphate (GGPP), into baccatin III in N. benthamiana, using a subset of nine enzymes (Fig. 2), thus, paving the way for the scalable production of key Taxol precursors, through metabolic engineering. Strikingly, some enzymes, such as T10βH and DBAT, which were previously shown to catalyze reactions in Taxol biosynthesis, were not required to form baccatin III.
Other recent studies have demonstrated that species of Taxus feature different enzymes and pathway branches to form Taxol and key intermediates. Zhang and colleagues engineered taxadiene production using cytosolic re-localization of the plastidial enzymes in N. benthamiana, reaching yields of 100 µg g−1 fresh weight that enabled the analysis of additional candidate genes identified in the Taxus genome (Zhang et al. 2023b). This approach uncovered T9ɑH (designated as CYP725A22-1 in this study), as well as two 2-oxoglutarate-Fe(II)-dependent dioxygenases that catalyze the oxidation of the C-9 hydroxyl group and formation of the oxetane ring, respectively, thus providing a separate set of 13 enzymes enabling these critical functional decorations of the Taxol backbone (Fig. 2). Further characterization of a T2’ɑH P450 enzyme (CYP73A171) and a β-phenylalanine-CoA ligase, with functions in forming the aromatic side chain, enabled the complete production of Taxol in N. benthamiana with a set of 17 enzymes (Zhang et al. 2023b).
Furthermore, Yang et al. also reported the characterization of T9αH (here designated CYP725A37) as well as the CYP725A55-catalyzed oxetane ester formation to form 1β-dehydroxy-baccatin VI (Yang et al. 2024). Motivated by a close review of previously proposed pathway reactions, another recent effort by Zhao and colleagues demonstrated that taxane 5ɑ-hydroxylase (T5ɑH, CYP725A4), a P450 identified to decorate the taxadiene scaffold at C-5 nearly three decades ago (Hefner et al. 1996), can act as a bifunctional enzyme, facilitating C-5 hydroxylation of two primary TXS products, taxa-4(5)-11(12)-diene and its isomer taxa-4(20)-11(12)-diene, and subsequent oxetane ring formation, as shown by engineering taxadiene production and T5ɑH co-expression in yeast and N. benthamiana (Zhao et al. 2024) (Fig. 3). In addition, Liu and coworkers combined promoter engineering with co-expression analysis to identify several previously unresolved products of T5ɑH, underscoring the functional promiscuity of this core P450 in the production of Taxol and other taxoids (Liu et al. 2024) (Fig. 3).
Catalytic plasticity: dynamic metabolic networks
These research advances not only discovered long sought-after pathway reactions in Taxol biosynthesis but, more broadly, highlight the potential of integrating systems biology, synthetic biology, and modern metabolomics and biochemical technologies to realize the discovery and engineering of multi-enzyme pathway networks en route to highly complex specialized metabolites that previously were unattainable. Notably, several findings suggest that similar to other diterpenoid pathways, the biosynthesis of Taxol and related taxoids is realized through a dynamic metabolic network, where individual enzyme modules can interact in different combinations to yield a broader product range (Bathe and Tissier 2019; Lanier et al. 2023; Peters 2006; Zerbe and Bohlmann 2015).
Firstly, the above-mentioned studies revealed that different enzymes are capable of generating the signature oxetane ring critical for the therapeutic efficacy of Taxol (Wang et al. 2000). Secondly, differences in the tissue-specific expression of several identified genes support the presence of tissue-specific pathways (Jiang et al. 2024). Thirdly, TXS, T5ɑH, and other Taxol-forming enzymes show expansive substrate- and product-promiscuity (Guerra-Bubb et al. 2012; Liu et al. 2024; Zhao et al. 2024) (Fig. 3), thus supplying substrates for alternate pathway branches toward the diverse array of taxanes and taxoids produced in species of yew (Lange and Conner 2021). Notably, the use of different minimal enzyme sets to produce baccatin III in N. benthamiana (Fig. 2) resulted in different product yields between 50 ng g−1 (Jiang et al. 2024) and 155 ng g−1 (Zhang et al. 2023b) plant material, suggesting that differences in enzyme combinations and pathway reconstitution affect pathway productivity.
The catalytic plasticity of Taxol biosynthesis presents both a challenge and an opportunity for metabolic engineering. Combinatorial pathway engineering of different enzyme modules can provide access to a range of structures, whereas lack of control over undesired branch pathways can substantially diminish product yield in heterologous systems (Andersen-Ranberg et al. 2016; De La Peña and Sattely 2021; Frey et al. 2024; Guo et al. 2016; Liu et al. 2024; Mafu et al. 2016). Although production yields of baccatin III and Taxol in yeast and N. benthamiana are still relatively low, advances in multi-enzyme pathway engineering, subcellular co-localization of enzyme modules, and engineering of microbial and plant host systems now offer the tools needed for developing large-scale Taxol production platforms (Jiang et al. 2024; Zhang et al. 2023b).
By integrating genomics-enabled gene discovery, enzyme co-expression approaches, and substrate feeding, a broader range of precursors can be accessed to fast-track the functional testing and annotation of enzyme superfamilies involved in the biosynthesis of all classes of plant-specialized metabolites (De La Peña and Sattely 2021; Frey et al. 2024; Kitaoka et al. 2015; Tiedge et al. 2020) (Fig. 3). To optimize pathway engineering toward Taxol and other desired products, a fundamental knowledge of the order of enzyme reactions and the spatial/temporal organization of pathways is required to enable the redirection of precursor flux and control enzyme expression levels, in heterologous systems that lack the native regulatory components (Ajikumar et al. 2010; Liu et al. 2024; Nowrouzi et al. 2024; Zhao et al. 2024). Complementary to pathway discovery and optimization discussed here, advances in metabolic engineering, fermentation, and plant biomass production, as well as semi-synthetic approaches are certain to continue boosting natural product titers in microbial and plant platforms (Wang et al. 2021; Biggs et al., 2021; Belcher et al. 2021). At the same time, rapid advances in metabolomics technologies enable the screening of a broad range of species across the plant kingdom and are certain to reveal new bioactive natural products as leads for drug discovery.
Conclusions
Continued efforts to decipher the structure–activity relationships of Taxol-biosynthetic enzymes will enable protein engineering to improve catalytic activity and specificity (Biggs et al. 2016; Edgar et al. 2016; Köksal et al. 2011; Liu et al. 2024; Schrepfer et al. 2016; You et al. 2018). Ultimately, combining the expansive tool kit, at the interface of modern biology and chemistry, can accelerate the discovery and sustainable manufacture of life-saving chemicals powered by plants.
Data availability
Data sharing is not applicable to this article as no datasets were generated or analyzed as part of this study.
References
Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G (2010) Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 330:70–74
Andersen-Ranberg J, Kongstad KT, Nielsen MT, Jensen NB, Pateraki I, Bach SS, Hamberger B, Zerbe P, Staerk D, Bohlmann J, Moller BL, Hamberger B (2016) Expanding the landscape of diterpene structural diversity through stereochemically controlled combinatorial biosynthesis. Angew Chem Int Ed Engl 55:2142–2146
Arnst J (2020) When taxol met tubulin. J Biol Chem 295:13994–13995
Arya SS, Rookes JE, Cahill DM, Lenka SK (2020) Next-generation metabolic engineering approaches towards development of plant cell suspension cultures as specialized metabolite producing biofactories. Biotechnol Adv 45:107635
Bathe U, Tissier A (2019) Cytochrome P450 enzymes: a driving force of plant diterpene diversity. Phytochemistry 161:149–162
Belcher MS, Mahinthakumar J, Keasling JD (2021) New frontiers: harnessing pivotal advances in microbial engineering for the biosynthesis of plant-derived terpenoids. Curr Opin Biotechnol 65:88–93
Biggs BW, Lim CG, Sagliani K, Shankar S, Stephanopoulos G, De Mey M, Ajikumar PK (2016) Overcoming heterologous protein interdependency to optimize P450-mediated taxol precursor synthesis in Escherichia coli. Proc Natl Acad Sci USA 113:3209–3214
Chang MCY, Eachus RA, Trieu W, Ro D-K, Keasling JD (2007) Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 3:274–277
Cheng J, Wang X, Liu X, Zhu X, Li Z, Chu H, Wang Q, Lou Q, Cai B, Yang Y, Lu X, Peng K, Liu D, Liu Y, Lu L, Liu H, Yang T, Ge Q, Shi C, Liu G, Dong Z, Xu X, Wang W, Jiang H, Ma Y (2021) Chromosome-level genome of Himalayan yew provides insights into the origin and evolution of the paclitaxel biosynthetic pathway. Mol Plant 14:1199–1209
Chen R, Wang M, Keasling JD, Hu T, Yin X (2024) Expanding the structural diversity of terpenes by synthetic biology approaches. Trend Biotechnol. https://doi.org/10.1016/j.tibtech.2023.12.006
De Luca V, Salim V, Atsumi SM, Yu F (2012) Mining the biodiversity of plants: a revolution in the making. Science 336:1658–1661
De La Peña R, Sattely ES (2021) Rerouting plant terpene biosynthesis enables momilactone pathway elucidation. Nat Chem Biol 17:205–212
Edgar S, Zhou K, Qao KJ, King JR, Simpson JH, Stephanopoulos G (2016) Mechanistic insights into taxadiene epoxidation by taxadiene-5 alpha-hydroxylase. ACS Chem Biol 11:460–469
Frey M, Bathe U, Meink L, Balcke GU, Schmidt J, Frolov A, Soboleva A, Hassanin A, Davari MD, Frank O, Schlagbauer V, Dawid C, Tissier A (2024) Combinatorial biosynthesis in yeast leads to over 200 diterpenoids. Metab Eng. https://doi.org/10.1016/j.ymben.2024.02.006
Guerra-Bubb J, Croteau R, Williams RM (2012) The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites. Nat Prod Rep 29:683–696
Guo J, Ma X, Cai Y, Ma Y, Zhan Z, Zhou YJ, Liu W, Guan M, Yang J, Cui G, Kang L, Yang L, Shen Y, Tang J, Lin H, Ma X, Jin B, Liu Z, Peters RJ, Zhao ZK, Huang L (2016) Cytochrome P450 promiscuity leads to a bifurcating biosynthetic pathway for tanshinones. New Phytol 210:525–534
Hardy K, Buckley S, Collins MJ, Estalrrich A, Brothwell D, Copeland L, Garcia-Tabernero A, Garcia-Vargas S, de la Rasilla M, Lalueza-Fox C, Huguet R, Bastir M, Santamaria D, Madella M, Wilson J, Cortes AF, Rosas A (2012) Neanderthal medics? evidence for food cooking and medicinal plants entrapped in dental calculus. Naturwissenschaften 99:617–626
Hartmann T (2007) From waste products to ecochemicals: 50 years research of plant secondary metabolism. Phytochemistry 68:2831–2846
Hasan MM, Kim HS, Jeon JH, Kim SH, Moon B, Song JY, Shim SH, Baek KH (2014) Metabolic engineering of Nicotiana benthamiana for the increased production of taxadiene. Plant Cell Rep 33:895–904
Hefner J, Rubenstein SM, Ketchum RE, Gibson DM, Williams RM, Croteau R (1996) Cytochrome P450-catalyzed hydroxylation of taxa-4(5)11(12)-diene to taxa-4(20)11(12)-dien-5alpha-ol: the first oxygenation step in taxol biosynthesis. Chem Biol 3:479–489
Hetzler BE, Trauner D, Lawrence AL (2022) Natural product anticipation through synthesis. Nat Rev Chem 6:170–181
Hezari M, Ketchum RE, Gibson DM, Croteau R (1997) Taxol production and taxadiene synthase activity in Taxus canadensis cell suspension cultures. Arch Biochem Biophys 337:185–190
Hezari M, Lewis NG, Croteau R (1995) Purification and characterization of taxa-4(5)11(12)-diene synthase from Pacific yew (Taxus brevifolia) that catalyzes the first committed step of taxol biosynthesis. Arch Biochem Biophys 322:437–444
Jennewein S, Croteau R (2001) Taxol: biosynthesis molecular genetics and biotechnological applications. Appl Microbiol Biotechnol 57:13–19
Jiang B, Gao L, Wang H, Sun Y, Zhang X, Ke H, Liu S, Ma P, Liao Q, Wang Y, Wang H, Liu Y, Du R, Rogge T, Li W, Shang Y, Houk KN, Xiong X, Xie D, Huang S, Lei X, Yan J (2024) Characterization and heterologous reconstitution of biosynthetic enzymes leading to baccatin III. Science 383:622–629
Kaspera R, Croteau R (2006) Cytochrome P450 oxygenases of taxol biosynthesis. Phytochem Rev 5:433–444
Ketchum REB, Rithner CD, Qiu D, Kim YS, Williams RM, Croteau RB (2003) Taxus metabolomics: methyl jasmonate preferentially induces production of taxoids oxygenated at C-13 in Taxus x media cell cultures. Phytochemistry 62:901–909
Ketchum REB, Wherland L, Croteau RB (2007) Stable transformation and long-term maintenance of transgenic taxus cell suspension cultures. Plant Cell Rep 26:1025–1033
Kitaoka N, Lu X, Yang B, Peters RJ (2015) The application of synthetic biology to elucidation of plant mono-sesqui- and diterpenoid metabolism. Mol Plant 8:6–16
Köksal M, Jin Y, Coates RM, Croteau R, Christianson DW (2011) Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis. Nature 469:116–120
Lange BM, Conner CF (2021) Taxanes and taxoids of the genus taxus-a comprehensive inventory of chemical diversity. Phytochemistry 190:112829
Lanier ER, Andersen TB, Hamberger B (2023) Plant terpene specialized metabolism: complex networks or simple linear pathways? Plant J 114:1178–1201
Li J, Mutanda I, Wang K, Yang L, Wang J, Wang Y (2019) Chloroplastic metabolic engineering coupled with isoprenoid pool enhancement for committed taxanes biosynthesis in Nicotiana benthamiana. Nat Commun 10:4850
Li X, Gadar-Lopez AE, Chen L, Jayachandran S, Cruz-Morales P, Keasling JD (2023) Mining natural products for advanced biofuels and sustainable bioproducts. Curr Opin Biotechnol 84:103003
Lin X, Hezari M, Koepp AE, Floss HG, Croteau R (1996) Mechanism of taxadiene synthase a diterpene cyclase that catalyzes the first step of taxol biosynthesis in Pacific yew. Biochemistry 35:2968–2977
Liu JCT, De La Peña R, Tocol C, Sattely ES (2024) Reconstitution of early paclitaxel biosynthetic network. Nat Commun 15:1419
Mafu S, Jia M, Zi J, Morrone D, Wu Y, Xu M, Hillwig ML, Peters RJ (2016) Probing the promiscuity of ent-kaurene oxidases via combinatorial biosynthesis. Proc Natl Acad Sci USA 113:2526–2531
Mayor S (2011) Tree that provides paclitaxel is put on list of endangered species. BMJ 343:d7411
Nowrouzi B, Li RA, Walls LE, d’Espaux L, Malcl K, Liang L, Jonguitud-Borrego N, Lerma-Escalera AI, Morones-Ramirez JR, Keasling JD, Rios-Solis L (2020) Enhanced production of taxadiene in Saccharomyces cerevisiae. Microb Cell Fact 19:200
Nowrouzi B, Torres-Montero P, Kerkhoven EJ, Martínez JL, Rios-Solis L (2024) Rewiring metabolism for optimised taxol® precursors production. Metab Eng Commun 18:e00229
Owen C, Patron NJ, Huang A, Osbourn A (2017) Harnessing plant metabolic diversity. Curr Opin Chem Biol 40:24–30
Peters RJ (2006) Uncovering the complex metabolic network underlying diterpenoid phytoalexin biosynthesis in rice and other cereal crop plants. Phytochemistry 67:2307–2317
Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, O’Neal JM, Cornwell T, Pastor I, Fridlender B (2002) Plants and human health in the 21 century. Trends Biotechnol 20:522–531
Roberts SC (2007) Production and engineering of terpenoids in plant cell culture. Nat Chem Biol 3:387–395
Schrepfer P, Buettner A, Goerner C, Hertel M, van Rijn J, Wallrapp F, Eisenreich W, Sieber V, Kourist R, Brück T (2016) Identification of amino acid networks governing catalysis in the closed complex of class I terpene synthases. Proc Natl Acad Sci USA 113:E958–E967
Srividya N, Lange I, Hartmann M, Li Q, Mirzaei M, Lange BM (2020) Biochemical characterization of acyl activating enzymes for side chain moieties of taxol and its analogs. J Biol Chem 295:4963–4973
Tiedge K, Muchlinski A, Zerbe P (2020) Genomics-enabled analysis of specialized metabolism in bioenergy crops: current progress and challenges. Synth Biol. https://doi.org/10.1093/synbio/ysaa005
Walker K, Croteau R (2001) Taxol biosynthetic genes. Phytochemistry 58:1–7
Walls LE, Malc K, Nowrouzi B, Li RA, d’Espaux L, Wong J, Dennis JA, Semião AJC, Wallace S, Martinez JL, Keasling JD, Rios-Solis L (2021) Optimizing the biosynthesis of oxygenated and acetylated taxol precursors in Saccharomyces cerevisiae using advanced bioprocessing strategies. Biotechnol Bioeng 118:279–293
Wang M, Cornett B, Nettles J, Liotta DC, Snyder JP (2000) The oxetane ring in taxol. J Org Chem 65:1059–1068
Wang H, Zhang BY, Gong T, Chen TJ, Chen JJ, Yang JL, Zhu P (2021) Construction of acetyl-CoA and DBAT hybrid metabolic pathway for acetylation of 10-deacetylbaccatin III to baccatin III. Acta Pharm Sin B 11:3322–3334
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents VI. The isolation and structure of taxol a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327
Watanabe T, Oga K, Matoba H, Nagatomo M, Inoue M (2023) Total synthesis of taxol enabled by intermolecular radical coupling and Pd-catalyzed cyclization. J Am Chem Soc 145:25894–25902
Wildung MR, Croteau R (1996) A cDNA clone for taxadiene synthase the diterpene cyclase that catalyzes the committed step of taxol biosynthesis. J Biol Chem 271:9201–9204
Wurtzel ET, Kutchan TM (2016) Plant metabolism the diverse chemistry set of the future. Science 353:1232–1236
Xiong X, Gou J, Liao Q, Li Y, Zhou Q, Bi G, Li C, Du R, Wang X, Sun T, Guo L, Liang H, Lu P, Wu Y, Zhang Z, Ro D-K, Shang Y, Huang S, Yan J (2021) The taxus genome provides insights into paclitaxel biosynthesis. Nat Plant 7:1026–1036
Yang C, Wang Y, Su Z, Xiong L, Wang P, Lei W, Yan X, Ma D, Zhao G, Zhou Z (2024) Biosynthesis of the highly oxygenated tetracyclic core skeleton of taxol. Nat Commun 15:2339
You L-F, Huang J-J, Wei T, Lin S-L, Jiang B-H, Guo L-Q, Lin J-F (2018) Enhanced catalytic activities and modified substrate preferences for taxoid 10β-O-acetyl transferase mutants by engineering catalytic histidine residues. Biotechnol Lett 40:1245–1251
Zerbe P, Bohlmann J (2015) Plant diterpene synthases: exploring modularity and metabolic diversity for bioengineering. Trend Biotechnol 33:419–428
Zhang S, Ye T, Liu Y, Hou G, Wang Q, Zhao F, Li F, Meng Q (2023a) Research advances in clinical applications anticancer mechanism total chemical synthesis semi-synthesis and biosynthesis of paclitaxel. Molecules 28:7517
Zhang Y, Wiese L, Fang H, Alseekh S, Perez de Souza L, Scossa F, Molloy J, Christmann M, Fernie AR (2023b) Synthetic biology identifies the minimal gene set required for paclitaxel biosynthesis in a plant chassis. Mol Plant 16:1951–1961
Zhao Y, Liang F, Xie Y, Duan Y-T, Andeadelli A, Pateraki I, Makris AM, Pomorski TG, Staerk D, Kampranis SC (2024) Oxetane ring formation in taxol biosynthesis is catalyzed by a bifunctional cytochrome P450 enzyme. J Am Chem Soc 146:801–810
Acknowledgements
The author is supported by the National Institutes of Health R01 (grant 5R01AT010593-03) and the National Science Foundation TRTech-PGR (grant 2312181).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares that they have no conflict of interest.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zerbe, P. Plants against cancer: towards green Taxol production through pathway discovery and metabolic engineering. aBIOTECH (2024). https://doi.org/10.1007/s42994-024-00170-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42994-024-00170-8